Ultrasound guided ablative-laser assisted photodynamic therapy of basal cell carcinoma (US-aL-PDT)
Language English Country United States Media print-electronic
Document type Comparative Study, Journal Article
PubMed
22316283
DOI
10.1089/pho.2011.3107
Knihovny.cz E-resources
- MeSH
- Carcinoma, Basal Cell diagnostic imaging pathology therapy MeSH
- Adult MeSH
- Esthetics MeSH
- Photochemotherapy methods MeSH
- Risk Assessment MeSH
- Immunohistochemistry MeSH
- Biopsy, Needle MeSH
- Cohort Studies MeSH
- Combined Modality Therapy MeSH
- Aminolevulinic Acid analogs & derivatives pharmacology MeSH
- Laser Therapy methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Skin Neoplasms diagnostic imaging pathology therapy MeSH
- Follow-Up Studies MeSH
- Face MeSH
- Prospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Ultrasonography MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
- Names of Substances
- Aminolevulinic Acid MeSH
- methyl 5-aminolevulinate MeSH Browser
OBJECTIVE: With proper noninvasive ultrasound measurement of tumor depth, case selection for laser pre-ablation followed by PDT is possible. This combination of methods provides a less invasive approach to the treatment of BCC. BACKGROUND DATA: Basal cell carcinoma (BCC) primarily affects the face, and, therefore, radical excision is problematic because of the possibility of poor aesthetic outcomes. Photodynamic therapy (PDT) offers an advantage in aesthetic outcomes, but topical PDT is only effective for tumors with a depth up to 2 mm. MATERIALS AND METHODS: Seventy-five histologically verified BCCs from 67 patients were selected and divided into three therapeutic groups based on the tumor depth, which was determined by 20 MHz skin ultrasound. The three groups were: A/<2 mm (PDT), B/ 2-3 mm (Er:YAG laser ablation+PDT), and C/>3 mm (diode laser ablation+PDT). The treatment consisted of laser ablation (or no ablation) followed by the application of methyl-aminolevulinate (MAL) and a 3-h treatment period using an occlusive bandage. Subsequently, illumination with 630 nm (MAL-PDT) was performed. MAL-PDT was repeated 1-3 weeks after the first treatment. A clinical evaluation was performed after 6 months. RESULTS: A 100% clearance rate (CR) in the group with the deepest tumors was observed. In addition, a 94.7% CR occurred in the group with tumors 2-3 mm in depth, and an 81.2% CR was observed in the group with superficial tumors. CONCLUSIONS: With proper ultrasound case selection and laser ablation before MAL-PDT, the depth of a BCC lesion is not a limiting factor for PDT, and aesthetic outcomes are very good. Therefore, ultrasound-guided ablative laser-assisted PDT of BCC can be the method of choice, particularly in aesthetically challenging cases.
References provided by Crossref.org